Plain-English translation of NCT06842147 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a portable, single-lead heart monitor worn for 7 days can catch irregular heartbeats (called atrial fibrillation or AF) earlier than a standard heart test alone. The study involves nearly 15,000 people age 60 and older in rural China, with some villages getting the extended monitoring and others receiving standard screening. Researchers want to see if catching irregular heartbeats sooner can prevent serious complications like stroke and heart failure over the following three years.
Irregular heartbeats often have no symptoms, so many people don't know they have them until it's too late and they've had a stroke or other serious problem. This trial is testing whether a longer, continuous heart monitor can find these dangerous rhythms earlier, when doctors can still treat them and prevent harm.
You likely qualify if…
You likely don't qualify if…
If you join, your village clinic will randomly assign you to either the standard screening group or the extended monitoring group. In either case, you'll receive a standard 12-lead heart test and education about irregular heartbeats and their risks. If you're in the extended monitoring group, you'll also wear a portable single-lead heart monitor for 7 days to check for any irregular rhythms. Researchers will follow you for up to 3 years to track whether you develop irregular heartbeats and whether you experience any serious heart events like stroke or heart failure.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China